Your search returned 12 results.

Results
	1.	Bystander killing effect of DS-8201a, a novel anti-human epidermal growth factor receptor 2 antibody-drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity. [electronic resource] by Ogitani, Yusuke Hagihara, Katsunobu Oitate, Masataka Naito, Hiroyuki Agatsuma, Toshinori Producer: 20170214 In: Cancer science vol. 107 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A HER2-Targeting Antibody-Drug Conjugate, Trastuzumab Deruxtecan (DS-8201a), Enhances Antitumor Immunity in a Mouse Model. [electronic resource] by Iwata, Tomomi Nakayama Ishii, Chiaki Ishida, Saori Ogitani, Yusuke Wada, Teiji Agatsuma, Toshinori Producer: 20190722 In: Molecular cancer therapeutics vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Pharmacokinetics of trastuzumab deruxtecan (T-DXd), a novel anti-HER2 antibody-drug conjugate, in HER2-positive tumour-bearing mice. [electronic resource] by Okamoto, Hiromi Oitate, Masataka Hagihara, Katsunobu Shiozawa, Hideyuki Furuta, Yoshitake Ogitani, Yusuke Kuga, Hiroshi Producer: 20200908 In: Xenobiotica; the fate of foreign compounds in biological systems vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance. [electronic resource] by Takegawa, Naoki Nonagase, Yoshikane Yonesaka, Kimio Sakai, Kazuko Maenishi, Osamu Ogitani, Yusuke Tamura, Takao Nishio, Kazuto Nakagawa, Kazuhiko Tsurutani, Junji Producer: 20171018 In: International journal of cancer vol. 141 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Novel antibody drug conjugates containing exatecan derivative-based cytotoxic payloads. [electronic resource] by Nakada, Takashi Masuda, Takeshi Naito, Hiroyuki Yoshida, Masao Ashida, Shinji Morita, Koji Miyazaki, Hideki Kasuya, Yuji Ogitani, Yusuke Yamaguchi, Junko Abe, Yuki Honda, Takeshi Producer: 20161107 In: Bioorganic & medicinal chemistry letters vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Calcitonin gene-related peptide is an important regulator of cutaneous immunity: effect on dendritic cell and T cell functions. [electronic resource] by Mikami, Norihisa Matsushita, Hiroaki Kato, Tetsuya Kawasaki, Rumi Sawazaki, Taichi Kishimoto, Taeko Ogitani, Yusuke Watanabe, Keiko Miyagi, Yayoi Sueda, Kaori Fukada, So-ichiro Yamamoto, Hiroshi Tsujikawa, Kazutake Producer: 20111007 In: Journal of immunology (Baltimore, Md. : 1950) vol. 186 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Calcitonin gene-related peptide regulates type IV hypersensitivity through dendritic cell functions. [electronic resource] by Mikami, Norihisa Sueda, Kaori Ogitani, Yusuke Otani, Ippei Takatsuji, Miku Wada, Yasuko Watanabe, Keiko Yoshikawa, Rintaro Nishioka, Satoshi Hashimoto, Nagisa Miyagi, Yayoi Fukada, So-ichiro Yamamoto, Hiroshi Tsujikawa, Kazutake Producer: 20140915 In: PloS one vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Wide application of a novel topoisomerase I inhibitor-based drug conjugation technology. [electronic resource] by Ogitani, Yusuke Abe, Yuki Iguchi, Takuma Yamaguchi, Junko Terauchi, Tomoko Kitamura, Michiko Goto, Koichi Goto, Mayumi Oitate, Masataka Yukinaga, Hideo Yabe, Yoshiyuki Nakada, Takashi Masuda, Takeshi Morita, Koji Agatsuma, Toshinori Producer: 20170808 In: Bioorganic & medicinal chemistry letters vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1. [electronic resource] by Ogitani, Yusuke Aida, Tetsuo Hagihara, Katsunobu Yamaguchi, Junko Ishii, Chiaki Harada, Naoya Soma, Masako Okamoto, Hiromi Oitate, Masataka Arakawa, Shingo Hirai, Takehiro Atsumi, Ryo Nakada, Takashi Hayakawa, Ichiro Abe, Yuki Agatsuma, Toshinori Producer: 20180131 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice. [electronic resource] by Tsujikawa, Kazutake Yayama, Katsutoshi Hayashi, Tamon Matsushita, Hiroaki Yamaguchi, Taijiro Shigeno, Tomomi Ogitani, Yusuke Hirayama, Megumi Kato, Tetsuya Fukada, So-ichiro Takatori, Shingo Kawasaki, Hiromu Okamoto, Hiroshi Ikawa, Masahito Okabe, Masaru Yamamoto, Hiroshi Producer: 20071213 In: Proceedings of the National Academy of Sciences of the United States of America vol. 104 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody-drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study. [electronic resource] by Doi, Toshihiko Shitara, Kohei Naito, Yoichi Shimomura, Akihiko Fujiwara, Yasuhiro Yonemori, Kan Shimizu, Chikako Shimoi, Tatsunori Kuboki, Yasutoshi Matsubara, Nobuaki Kitano, Atsuko Jikoh, Takahiro Lee, Caleb Fujisaki, Yoshihiko Ogitani, Yusuke Yver, Antoine Tamura, Kenji Producer: 20171215 In: The Lancet. Oncology vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	A Novel HER3-Targeting Antibody-Drug Conjugate, U3-1402, Exhibits Potent Therapeutic Efficacy through the Delivery of Cytotoxic Payload by Efficient Internalization. [electronic resource] by Hashimoto, Yuuri Koyama, Kumiko Kamai, Yasuki Hirotani, Kenji Ogitani, Yusuke Zembutsu, Akiko Abe, Manabu Kaneda, Yuki Maeda, Naoyuki Shiose, Yoshinobu Iguchi, Takuma Ishizaka, Tomomichi Karibe, Tsuyoshi Hayakawa, Ichiro Morita, Koji Nakada, Takashi Nomura, Taisei Wakita, Kenichi Kagari, Takashi Abe, Yuki Murakami, Masato Ueno, Suguru Agatsuma, Toshinori Producer: 20200921 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)